Kansas Nephrology Research Institute, LLC
Wichita, Kansas, United States
Medical clinic in Wichita, Kansas
1035 N Emporia Ave #158, Wichita, KS 67214
About Kansas Nephrology Research Institute, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
3
Pfizer
3
Gilead Sciences
2
Boehringer Ingelheim
1
Fresenius Medical Care North America
1
Ineos Healthcare Limited
1
Ironwood Pharmaceuticals, Inc.
1
Keryx Biopharmaceuticals
1
NewAmsterdam Pharma
1
NxStage Medical
1
Reata Pharmaceuticals, Inc.
1
Clinical Trials at Kansas Nephrology Research Institute, LLC
During the past decade, Kansas Nephrology Research Institute, LLC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
2008-04-01
2014-05-01
Completed
58
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
2009-07-01
2011-07-01
Terminated
657
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
2010-12-01
2013-08-01
Completed
256
A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
2012-01-17
2014-02-28
Completed
320
A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin
2012-05-31
2015-02-13
Completed
170
Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease
2014-06-01
2016-08-01
Completed
334
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
2014-10-01
2016-01-01
Completed
234
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kansas Nephrology Research Institute, LLC" #1 sponsor was "Bayer" with 3 trials, followed by "Pfizer" with 3 trials
sponsored, "Gilead Sciences" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Fresenius Medical Care North America"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas Nephrology Research Institute, LLC"
#1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Medical Nutrition USA, Inc." with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Kansas Nephrology Research Institute, LLC
According to Clinical.Site data, the most researched conditions in "Kansas Nephrology Research Institute, LLC" are
"Diabetic Kidney Disease" (2 trials), "ADPKD" (1 trials), "Anemia of Chronic Kidney Disease" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Kansas Nephrology Research Institute, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Kansas Nephrology Research Institute, LLC
Most popular intervention types in "Kansas Nephrology Research Institute, LLC" are "Drug" (12 trials), "Biological" (2 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Epoetin Hospira" (2 trials), "Finerenone (BAY94-8862)" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kansas Nephrology Research Institute, LLC
The vast majority of trials in "Kansas Nephrology Research Institute, LLC" are
16 trials for "All" genders.
Clinical Trials Status at Kansas Nephrology Research Institute, LLC
Currently, there are NaN active trials in "Kansas Nephrology Research Institute, LLC".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Kansas Nephrology Research Institute, LLC,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Kansas Nephrology Research Institute, LLC, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".